SAGE Therapeutics' Series B Round

SAGE Therapeutics raised a round of funding on October 16, 2013.

SAGE Therapeutics is a neuroscience-focused company developing medicines to treat rare and orphan diseases of the central nervous system (CNS). SAGE's lead program, SAGE-547, is in clinical developmen…

Articles about SAGE Therapeutics' Series B Round: